Townsend Richard Nolan — SEC Form 4 filings
SEC reporting owner CIK 1995218. 25 Form 4 filings on record with FilingPulse; latest filed 2026-08-19.
Transaction summary — filings shown
Covers all 25 filings on record, filed 2024-01-09 to 2026-08-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 24 legs across 19 filings — 206,317 shares, $1,964,913 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
- Largest priced transaction: sale of 27,931 shares @ $17.06 ($476,503) in Lexeo Therapeutics, Inc., filed 2024-07-12.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | Chief Executive Officer, Director | 25 | — | 24 legs · 206,317 sh · $1,964,913 | 27 |
Form 4 filings — Townsend Richard Nolan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-19 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Sale (S): 3,345 @ $4.95 | EDGAR |
| 2026-07-01 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Grant/award (A): 67,000 @ $0 · Sale (S): 25,947 @ $4.48 | EDGAR |
| 2026-05-20 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Sale (S): 3,342 @ $5.06 | EDGAR |
| 2026-04-07 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Sale (S): 55,000 @ $5.69 | EDGAR |
| 2026-03-17 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Grant/award (A): 2,623 @ $2.64 | EDGAR |
| 2026-02-20 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Sale (S): 10,173 @ $6.38 | EDGAR |
| 2026-02-06 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Grant/award (A): 161,665 @ $0 · Grant/award (A): 646,665 (derivative) @ $0 | EDGAR |
| 2025-11-20 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Sale (S): 1,127 @ $9.27 | EDGAR |
| 2025-10-17 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Grant/award (A): 33,000 @ $0 · Sale (S): 12,985 @ $8.94 · Sale (S): 148 @ $9.56 | EDGAR |
| 2025-09-16 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Grant/award (A): 2,193 @ $2.64 | EDGAR |
| 2025-09-10 | 4/A | Lexeo Therapeutics, Inc. (LXEO) | Sale (S): 1,115 @ $4.67 | EDGAR |
| 2025-08-20 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Sale (S): 2,735 @ $4.67 | EDGAR |
| 2025-05-20 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Sale (S): 1,074 @ $2.77 | EDGAR |
| 2025-04-01 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Grant/award (A): 2,128 @ $2.61 | EDGAR |
| 2025-02-21 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Sale (S): 4,326 @ $4.41 | EDGAR |
| 2025-01-10 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Grant/award (A): 103,750 @ $0 · Grant/award (A): 207,500 (derivative) @ $0 | EDGAR |
| 2024-12-12 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Option exercise (M): 2,500 @ $2.33 · Sale (S): 2,500 @ $8.20 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2024-11-13 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Option exercise (M): 2,500 @ $2.33 · Sale (S): 2,500 @ $7.82 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2024-10-15 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Option exercise (M): 5,000 @ $2.33 · Sale (S): 5,000 @ $8.10 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-09-11 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Option exercise (M): 5,000 @ $2.33 · Sale (S): 5,000 @ $10.65 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-08-13 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Option exercise (M): 5,000 @ $2.33 · Sale (S): 5,000 @ $11.53 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-07-12 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Option exercise (M): 5,000 @ $2.33 · Sale (S): 23,622 @ $16.45 · Sale (S): 3,347 @ $16.85 · Sale (S): 27,931 @ $17.06 · Sale (S): 100 @ $19.06 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-06-12 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Option exercise (M): 5,000 @ $2.33 · Sale (S): 2,962 @ $17.29 · Sale (S): 2,038 @ $18.18 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-05-14 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Option exercise (M): 5,000 @ $2.33 · Sale (S): 5,000 @ $13.22 · Option exercise (M): 5,000 (derivative) @ $2.33 | EDGAR |
| 2024-01-09 | 4 | Lexeo Therapeutics, Inc. (LXEO) | Grant/award (A): 43,750 @ $0 · Grant/award (A): 262,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1995218 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →